View source for Phenglutarimide

{{drugbox
| IUPAC_name        = 3-(2-diethylaminoethyl)-4-phenylpiperidine-2,6-dione
| image             = Phenglutarimide.png
| CAS_number        = 
| ATC_prefix        = N04
| ATC_suffix        = AA09 
| PubChem           = 92870
| DrugBank          = 
| C=17|H=24|N=2|O=2
| molecular_weight  = 288.385 g/mol
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK          =  <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 
}}
              __NOTOC__
{{SI}}
{{CMG}}

==Overview==

'''Phenglutarimide''' is a [[anticholinergic]] used as an anti-[[Parkinson's disease|parkinson]] drug.
==References==
{{Reflist|2}}

{{Anti-parkinson anticholinergic agents}}

[[Category:Anticholinergics]]
[[Category:Drug]]